Trump Media & Technology (DJTWW) had the highest return in January 2024 by a mid-cap US stock, returning 184%.

ASSET	MONTH	% RETURN
Trump Media & Technology (DJTWW)	January 2024	184.03%
Trump Media & Technology (DJT)	January 2024	115.14%
Dave (DAVE)	January 2024	112.39%
Arcutis Biotherapeutics (ARQT)	January 2024	85.17%
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS)	January 2024	82.77%
Sezzle (SEZL)	January 2024	80.91%
WM Technology (MAPSW)	January 2024	70%
Rumble (RUM)	January 2024	52.22%
GeneDx (WGS)	January 2024	42.59%
Oscar Health (OSCR)	January 2024	38.65%
Alvotech (ALVO)	January 2024	37.08%
Tarsus Pharmaceuticals (TARS)	January 2024	36.2%
Powell Industries (POWL)	January 2024	36.15%
Avidity Biosciences (RNA)	January 2024	35.59%
Advantage Solutions (ADVWW)	January 2024	32.01%
Merus (MRUS)	January 2024	31.61%
Viking Therapeutics (VKTX)	January 2024	30.28%
Innodata (INOD)	January 2024	29.63%
Kymera Therapeutics (KYMR)	January 2024	28.65%
Mineralys Therapeutics, Inc Common Stock (MLYS)	January 2024	28.5%
CG Oncology, Inc Common stock (CGON)	January 2024	28.48%
Appfolio (APPF)	January 2024	27.49%
Grupo Financiero Galicia SA ADR (GGAL)	January 2024	26.01%
Abivax SA American Depositary Shares (ABVX)	January 2024	25.76%
Sarepta Therapeutics (SRPT)	January 2024	24.6%

Mid-cap stocks are treated as having a market cap between $2B and $10B.